Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment
Front Endocrinol (Lausanne)
.
2023 Jun 30:14:1206642.
doi: 10.3389/fendo.2023.1206642.
eCollection 2023.
Authors
Zhe Huang
1
,
Dewei Ye
2
,
Kerry Loomes
3
,
Kenneth Kingyip Cheng
4
,
Hannah Xiaoyan Hui
5
Affiliations
1
Department of Genetics and Developmental Science, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
2
Key Laboratory of Metabolic Phenotyping in Model Animals, Guangdong Pharmaceutical University, Guangzhou, China.
3
School of Biological Sciences and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
4
Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR, China.
5
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
PMID:
37469990
PMCID:
PMC10352314
DOI:
10.3389/fendo.2023.1206642
No abstract available
Keywords:
MAFLD; biological marker; calcium signalling; metabolic disorders; obesity.
Publication types
Editorial
MeSH terms
Humans
Liver Diseases* / diagnosis
Liver Diseases* / pathology
Liver Diseases* / therapy